Malaysia Pharma Market Snapshot
The growth of the Malaysian pharma market between 2006 and 2016. Pharmaceutical sales grew to over USD 2 billion by 2016, thanks in large part to a burgeoning prescription medicine…
Malaysia
Southeast Asia / More Indonesian License Suspensions; Kalbe's Aventis Share Purchase; Boston Scientific's Malaysia Expansion
The biggest pharma stories from Southeast Asia, including GSK's new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia's acute kidney injury crisis, Kalbe's Aventis share purchase, China-based MGI Tech's participation in Thailand's genomics initiative and…
Malaysia Pharma Market Snapshot
The growth of the Malaysian pharma market between 2006 and 2016. Pharmaceutical sales grew to over USD 2 billion by 2016, thanks in large part to a burgeoning prescription medicine…
Malaysia’s MYSalam Low-Income Healthcare Programme: A Modest Proposal
Eurasia Group’s Aditya Bhattacharji discusses the relatively modest scope of Malaysia’s recently-launched ‘MYSalam’ scheme; a healthcare programme which aims to provide coverage to the country’s bottom 40 percent of earners.…